Medscape (3/2, Lowes) reports, “The US Food and Drug Administration (FDA) today announced that it is revising the labels of certain statins as well as protease inhibitors for HIV and hepatitis C virus (HCV) to warn about interactions between the 2 sets of drugs that could increase the risk for myopathy and kidney failure.” The Article [...]
Coumadin Recalled
May 4, 2011 By
Bristol-Myers Squibb has alerted the FDA and initiated the recall of one lot of Coumadin, after an oversized tablet was discovered. Coumadin, also known as warfarin, is an anticoagulant or blood thinner prescribed for individuals with an increased risk of blood clots. An overdose would create an increased risk of bleeding. The recall applies to [...]